Delivery Order #15B10926F00000132

McKesson Corporation Delivers Medications for Opioid Treatment under VA Prime Vendor Contract

This FPDS award represents a definitive delivery order contract under the Pharmaceutical Prime Vendor Contract (PPV), an indefinite delivery vehicle established to facilitate pharmaceutical supplies for the Department of Veterans Affairs (VA). The recipient, McKesson Corporation, a leading pharmaceutical distributor, is tasked with providing controlled and non-controlled medications specifically for inmate use in opioid use disorder treatment, namely Medication-Assisted Treatment (MAT) therapy. The contract's significance is underscored by its role in supporting public health initiatives targeting opioid addiction among the inmate population, thereby contributing to broader efforts in combating substance abuse. The scope of work covers the purchase and delivery of multiple invoices of medications needed for the fiscal year, ensuring a consistent supply of therapeutic drugs. This award was made as a delivery order under the existing PPV contract, which was competitively awarded with full and open competition to McKesson. The performance period extends for approximately one year, highlighting an ongoing commitment to this critical healthcare service. A recent modification adjusted funding slightly, reflecting routine contract administration. This award complements McKesson's broader role as the prime vendor supplying pharmaceuticals to the VA, reinforcing its integral position in veteran and inmate healthcare.

Description

MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY26 1-30 SEPT

View original record